Adipocytes as regulators of energy balance and glucose homeostasis (original) (raw)
Mokdad, A. H. et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. J. Am. Med. Assoc.289, 76–79 (2003). Article Google Scholar
Bray, G. A. & Bellanger, T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine29, 109–117 (2006). ArticleCASPubMed Google Scholar
Trayhurn, P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol. Scand.184, 285–293 (2005). ArticleCASPubMed Google Scholar
Pond, C. M. The Fats of Life (Cambridge Univ. Press, Cambridge, 1998). Book Google Scholar
Giorgino, F., Laviola, L. & Eriksson, J. W. Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Acta Physiol. Scand.183, 13–30 (2005). ArticleCASPubMed Google Scholar
Green, H. & Kehinde, O. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell5, 19–27 (1975). ArticleCASPubMed Google Scholar
Hansen, J. B. & Kristiansen, K. Regulatory circuits controlling white versus brown adipocyte differentiation. Biochem. J.398, 153–168 (2006). ArticleCASPubMedPubMed Central Google Scholar
Rosen, E. D. et al. PPARγ is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell4, 611–617 (1999). ArticleCASPubMed Google Scholar
Tontonoz, P., Hu, E. & Spiegelman, B. M. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell79, 1147–1156 (1994). ArticleCASPubMed Google Scholar
Oishi, Y. et al. Kruppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab.1, 27–39 (2005). ArticleCASPubMed Google Scholar
Mori, T. et al. Role of Kruppel-like factor 15 (KLF15) in transcriptional regulation of adipogenesis. J. Biol. Chem.280, 12867–12875 (2005). ArticleCASPubMed Google Scholar
Banerjee, S. S. et al. The Kruppel-like factor KLF2 inhibits peroxisome proliferator-activated receptor-γ expression and adipogenesis. J. Biol. Chem.278, 2581–2584 (2003). ArticlePubMedCAS Google Scholar
Chen, Z., Torrens, J. I., Anand, A., Spiegelman, B. M. & Friedman, J. M. Krox20 stimulates adipogenesis via C/EBPβ-dependent and -independent mechanisms. Cell Metab.1, 93–106 (2005). ArticleCASPubMed Google Scholar
Akerblad, P., Lind, U., Liberg, D., Bamberg, K. & Sigvardsson, M. Early B-cell factor (O/E-1) is a promoter of adipogenesis and involved in control of genes important for terminal adipocyte differentiation. Mol. Cell Biol.22, 8015–8025 (2002). ArticleCASPubMedPubMed Central Google Scholar
Hansen, J. B. et al. Retinoblastoma protein functions as a molecular switch determining white versus brown adipocyte differentiation. Proc. Natl Acad. Sci. USA101, 4112–4117 (2004). ArticleADSCASPubMedPubMed Central Google Scholar
Scime, A. et al. Rb and p107 regulate preadipocyte differentiation into white versus brown fat through repression of PGC-1α. Cell Metab.2, 283–295 (2005). ArticleCASPubMed Google Scholar
Picard, F. et al. SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell111, 931–941 (2002). ArticleCASPubMed Google Scholar
Puigserver, P. et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell92, 829–839 (1998). ArticleCASPubMed Google Scholar
Puigserver, P. Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-α. Int. J. Obes. (Lond.)29 (Suppl. 1), S5–S9 (2005). ArticleCAS Google Scholar
Uldry, M. et al. Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation. Cell Metab.3, 333–341 (2006). ArticleCASPubMed Google Scholar
Schwartz, M. W. et al. Is the energy homeostasis system inherently biased toward weight gain? Diabetes52, 232–238 (2003). ArticleCASPubMed Google Scholar
Abizaid, A., Gao, Q. & Horvath, T. L. Thoughts for food: brain mechanisms and peripheral energy balance. Neuron51, 691–702 (2006). ArticleCASPubMed Google Scholar
Mauer, M. M., Harris, R. B. & Bartness, T. J. The regulation of total body fat: lessons learned from lipectomy studies. Neurosci. Biobehav. Rev.25, 15–28 (2001). ArticleCASPubMed Google Scholar
Friedman, J. M. Leptin and the regulation of body weight. Harvey Lect.95, 107–136 (1999). CASPubMed Google Scholar
Friedman, J. M. The function of leptin in nutrition, weight, and physiology. Nutr. Rev.60, S1–S14 (2002). ArticlePubMed Google Scholar
Halaas, J. L. et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science269, 543–546 (1995). ArticleADSCASPubMed Google Scholar
Pelleymounter, M. A. et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science269, 540–543 (1995). ArticleADSCASPubMed Google Scholar
Schwartz, M. W., Seeley, R. J., Campfield, L. A., Burn, P. & Baskin, D. G. Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest.98, 1101–1106 (1996). ArticleCASPubMedPubMed Central Google Scholar
Bjorbaek, C. & Kahn, B. B. Leptin signaling in the central nervous system and the periphery. Recent Prog. Horm. Res.59, 305–331 (2004). ArticleCASPubMed Google Scholar
Fei, H. et al. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc. Natl Acad. Sci. USA94, 7001–7005 (1997). ArticleADSCASPubMedPubMed Central Google Scholar
Balthasar, N. et al. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell123, 493–505 (2005). ArticleCASPubMed Google Scholar
Grill, H. J. Distributed neural control of energy balance: contributions from hindbrain and hypothalamus. Obesity (Silver Spring)14 (Suppl. 5), 216S–221S (2006). Google Scholar
Bartness, T. J. & Bamshad, M. Innervation of mammalian white adipose tissue: implications for the regulation of total body fat. Am. J. Physiol.275, R1399–R1411 (1998). CASPubMed Google Scholar
Bartness, T. J., Kay Song, C., Shi, H., Bowers, R. R. & Foster, M. T. Brain–adipose tissue cross talk. Proc. Nutr. Soc.64, 53–64 (2005). ArticleCASPubMed Google Scholar
Yamada, T. et al. Signals from intra-abdominal fat modulate insulin and leptin sensitivity through different mechanisms: neuronal involvement in food-intake regulation. Cell Metab.3, 223–229 (2006). ArticleCASPubMed Google Scholar
Bachman, E. S. et al. βAR signaling required for diet-induced thermogenesis and obesity resistance. Science297, 843–845 (2002). ArticleADSCASPubMed Google Scholar
Lowell, B. B. et al. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature366, 740–742 (1993). ArticleADSCASPubMed Google Scholar
Enerback, S. et al. Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature387, 90–94 (1997). ArticleADSCASPubMed Google Scholar
Abu-Elheiga, L., Matzuk, M. M., Abo-Hashema, K. A. & Wakil, S. J. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science291, 2613–2616 (2001). ArticleADSCASPubMed Google Scholar
Parker, M. G., Christian, M. & White, R. The nuclear receptor co-repressor RIP140 controls the expression of metabolic gene networks. Biochem. Soc. Trans.34, 1103–1106 (2006). ArticleCASPubMed Google Scholar
Qi, L. et al. TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism. Science312, 1763–1766 (2006). ArticleADSCASPubMed Google Scholar
Herman, M. A. & Kahn, B. B. Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J. Clin. Invest.116, 1767–1775 (2006). ArticleCASPubMedPubMed Central Google Scholar
Tirone, T. A. & Brunicardi, F. C. Overview of glucose regulation. World J. Surg.25, 461–467 (2001). ArticleCASPubMed Google Scholar
Kahn, B. B. Lilly lecture 1995. Glucose transport: pivotal step in insulin action. Diabetes45, 1644–1654 (1996). ArticleCASPubMed Google Scholar
Schwartz, M. W. et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes45, 531–535 (1996). ArticleCASPubMed Google Scholar
Farooqi, I. S. et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J. Clin. Invest.110, 1093–1103 (2002). ArticleCASPubMedPubMed Central Google Scholar
Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S. & Goldstein, J. L. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature401, 73–76 (1999). ArticleADSCASPubMed Google Scholar
Oral, E. A. et al. Leptin-replacement therapy for lipodystrophy. N. Engl. J. Med.346, 570–578 (2002). ArticleCASPubMed Google Scholar
Heymsfield, S. B. et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. J. Am Med. Assoc.282, 1568–1575 (1999). ArticleCAS Google Scholar
Minokoshi, Y. et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature415, 339–343 (2002). ArticleADSCASPubMed Google Scholar
Kamohara, S., Burcelin, R., Halaas, J. L., Friedman, J. M. & Charron, M. J. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature389, 374–377 (1997). ArticleADSCASPubMed Google Scholar
Kieffer, T. J. & Habener, J. F. The adipoinsular axis: effects of leptin on pancreatic β-cells. Am. J. Physiol. Endocrinol. Metab.278, E1–E14 (2000). ArticleCASPubMed Google Scholar
Covey, S. D. et al. The pancreatic β cell is a key site for mediating the effects of leptin on glucose homeostasis. Cell Metab.4, 291–302 (2006). ArticleCASPubMed Google Scholar
Kadowaki, T. et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest.116, 1784–1792 (2006). ArticleCASPubMedPubMed Central Google Scholar
Waki, H. et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J. Biol. Chem.278, 40352–40363 (2003). ArticleCASPubMed Google Scholar
Pajvani, U. B. et al. Structure–function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J. Biol. Chem.278, 9073–9085 (2003). ArticleCASPubMed Google Scholar
Yamauchi, T. et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature423, 762–769 (2003). ArticleADSCASPubMed Google Scholar
Hug, C. et al. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc. Natl Acad. Sci. USA101, 10308–10313 (2004). ArticleADSCASPubMedPubMed Central Google Scholar
Arita, Y. et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun.257, 79–83 (1999). ArticleCASPubMed Google Scholar
Yatagai, T. et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism52, 1274–1278 (2003). ArticleCASPubMed Google Scholar
Hotta, K. et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes50, 1126–1133 (2001). ArticleCASPubMed Google Scholar
Kubota, N. et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem.277, 25863–25866 (2002). ArticleCASPubMed Google Scholar
Ma, K. et al. Increased β-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J. Biol. Chem.277, 34658–34661 (2002). ArticleCASPubMed Google Scholar
Maeda, N. et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nature Med.8, 731–737 (2002). ArticleADSCASPubMed Google Scholar
Nawrocki, A. R. et al. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor γ agonists. J. Biol. Chem.281, 2654–2660 (2006). ArticleCASPubMed Google Scholar
Kubota, N. et al. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J. Biol. Chem.281, 8748–8755 (2006). ArticleCASPubMed Google Scholar
Maeda, N. et al. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes50, 2094–2099 (2001). ArticleCASPubMed Google Scholar
Winzell, M. S., Nogueiras, R., Dieguez, C. & Ahren, B. Dual action of adiponectin on insulin secretion in insulin-resistant mice. Biochem. Biophys. Res. Commun.321, 154–160 (2004). ArticlePubMedCAS Google Scholar
Fukuhara, A. et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science307, 426–430 (2005). ArticleADSCASPubMed Google Scholar
Stephens, J. M. & Vidal-Puig, A. J. An update on visfatin/pre-B cell colony-enhancing factor, an ubiquitously expressed, illusive cytokine that is regulated in obesity. Curr. Opin. Lipidol.17, 128–131 (2006). ArticleCASPubMed Google Scholar
Yang, H., Lavu, S. & Sinclair, D. A. Nampt/PBEF/Visfatin: a regulator of mammalian health and longevity? Exp. Gerontol.41, 718–726 (2006). ArticleCASPubMedPubMed Central Google Scholar
Yang, R. Z. et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am. J. Physiol. Endocrinol. Metab.290, E1253–E1261 (2006). ArticleCASPubMed Google Scholar
Hotamisligil, G. S. The role of TNFα and TNF receptors in obesity and insulin resistance. J. Intern. Med.245, 621–625 (1999). ArticleCASPubMed Google Scholar
Xu, H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest.112, 1821–1830 (2003). ArticleCASPubMedPubMed Central Google Scholar
Carey, A. L. et al. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes55, 2688–2697 (2006). ArticleCASPubMed Google Scholar
Rotter, V., Nagaev, I. & Smith, U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects. J. Biol. Chem.278, 45777–45784 (2003). ArticleCASPubMed Google Scholar
Hirosumi, J. et al. A central role for JNK in obesity and insulin resistance. Nature420, 333–336 (2002). ArticleADSCASPubMed Google Scholar
Shoelson, S. E., Lee, J. & Yuan, M. Inflammation and the IKKβ/IκB/NF-κB axis in obesity- and diet-induced insulin resistance. Int. J. Obes. Relat. Metab. Disord.27 (Suppl. 3), S49–S52 (2003). ArticleCASPubMed Google Scholar
Howard, J. K. & Flier, J. S. Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol. Metab.17, 365–371 (2006). ArticleCASPubMed Google Scholar
Houstis, N., Rosen, E. D. & Lander, E. S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature440, 944–948 (2006). ArticleADSCASPubMed Google Scholar
Steppan, C. M. & Lazar, M. A. The current biology of resistin. J. Intern. Med.255, 439–447 (2004). ArticleCASPubMed Google Scholar
Patel, S. D., Rajala, M. W., Rossetti, L., Scherer, P. E. & Shapiro, L. Disulfide-dependent multimeric assembly of resistin family hormones. Science304, 1154–1158 (2004). ArticleADSCASPubMed Google Scholar
Kaser, S. et al. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem. Biophys. Res. Commun.309, 286–290 (2003). ArticleCASPubMed Google Scholar
Patel, L. et al. Resistin is expressed in human macrophages and directly regulated by PPARγ activators. Biochem. Biophys. Res. Commun.300, 472–476 (2003). ArticleCASPubMed Google Scholar
Yang, Q. et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature436, 356–362 (2005). ArticleADSCASPubMed Google Scholar
Graham, T. E. et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N. Engl. J. Med.354, 2552–2563 (2006). ArticleCASPubMed Google Scholar
Roden, M. et al. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes49, 701–707 (2000). ArticleCASPubMed Google Scholar
Griffin, M. E. et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes48, 1270–1274 (1999). ArticleCASPubMed Google Scholar
Schmitz-Peiffer, C. et al. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes46, 169–178 (1997). ArticleCASPubMed Google Scholar
Paolisso, G. et al. Does free fatty acid infusion impair insulin action also through an increase in oxidative stress? J. Clin. Endocrinol. Metab.81, 4244–4248 (1996). ArticleCASPubMed Google Scholar
Hajduch, E. et al. Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. Diabetologia44, 173–183 (2001). ArticleCASPubMed Google Scholar
Song, M. J., Kim, K. H., Yoon, J. M. & Kim, J. B. Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem. Biophys. Res. Commun.346, 739–745 (2006). ArticleCASPubMed Google Scholar
Eldor, R. & Raz, I. Lipotoxicity versus adipotoxicity — the deleterious effects of adipose tissue on beta cells in the pathogenesis of type 2 diabetes. Diabetes Res. Clin. Pract.74, S3–S8 (2006). ArticleCAS Google Scholar
Lowell, B. B. & Shulman, G. I. Mitochondrial dysfunction and type 2 diabetes. Science307, 384–387 (2005). ArticleADSCASPubMed Google Scholar
Simha, V. & Garg, A. Lipodystrophy: lessons in lipid and energy metabolism. Curr. Opin. Lipidol.17, 162–169 (2006). ArticleCASPubMed Google Scholar
Yamauchi, T. et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Med.7, 941–946 (2001). ArticleCASPubMed Google Scholar
Weisberg, S. P. et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest.116, 115–124 (2006). ArticleCASPubMed Google Scholar
Kanda, H. et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest.116, 1494–1505 (2006). ArticleCASPubMedPubMed Central Google Scholar
Kamei, N. et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J. Biol. Chem.281, 26602–26614 (2006). ArticleCASPubMed Google Scholar
Di Gregorio, G. B. et al. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes54, 2305–2313 (2005). ArticleCASPubMed Google Scholar
Gnudi, L., Tozzo, E., Shepherd, P. R., Bliss, J. L. & Kahn, B. B. High level overexpression of glucose transporter-4 driven by an adipose-specific promoter is maintained in transgenic mice on a high fat diet, but does not prevent impaired glucose tolerance. Endocrinology136, 995–1002 (1995). ArticleCASPubMed Google Scholar
Abel, E. D. et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature409, 729–733 (2001). ArticleADSCASPubMed Google Scholar
Fukuchi, K. et al. Radionuclide imaging metabolic activity of brown adipose tissue in a patient with pheochromocytoma. Exp. Clin. Endocrinol. Diabetes112, 601–603 (2004). ArticleCASPubMed Google Scholar